UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression

Cancer medicine (Malden, MA), 2020-07, Vol.9 (13), p.4527-4539

2020

Link zum Volltext

Verfügbarkeit prüfen

Versorgungsforschung: Tumorregister Lymphatische Neoplasien

Onkologie, 2013, Vol.36 (s1), p.27-28

Abenhardt, Wolfgang

2013

Link zum Volltext

Verfügbarkeit prüfen

Bendamustin plus Rituximab für NHL-Patienten

Im Focus Onkologie, 2013-06, Vol.16 (6), p.20-20

2013

Link zum Volltext

Verfügbarkeit prüfen

Similar effectiveness of R‐CHOP‐14 and ‐21 in diffuse large B‐cell lymphoma—data from the prospective German Tumour Registry Lymphatic Neoplasms

European journal of haematology, 2019-11, Vol.103 (5), p.460-471

2019

Link zum Volltext

Verfügbarkeit prüfen

Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22 (8), p.e777-e787

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry

BMC cancer, 2014-11, Vol.14 (1), p.806-806, Article 806

2014

Link zum Volltext

Verfügbarkeit prüfen

Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma

Journal of neuro-oncology, 2016-12, Vol.130 (3), p.591-599

2016

Link zum Volltext

Verfügbarkeit prüfen

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

Breast (Edinburgh), 2018-02, Vol.37, p.42-51

2018

Link zum Volltext

Verfügbarkeit prüfen

Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms

Hematological oncology, 2021-08, Vol.39 (3), p.313-325

2021

Link zum Volltext

Verfügbarkeit prüfen

1st-Line Treatment with R-CHOP-14 or R-CHOP-21 in Patients with High-Grade Non-Hodgkin’s Lymphoma Is Similarly Effective: Data from the German Prospective TLN Registry

Blood, 2014-12, Vol.124 (21), p.4406-4406

2014

Link zum Volltext

Verfügbarkeit prüfen

Consolidation with alemtuzumab improves progression‐free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long‐term follow‐up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

British journal of haematology, 2009-01, Vol.144 (1), p.95-98

2009

Link zum Volltext

Verfügbarkeit prüfen

Response To 1st-Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry

Blood, 2013-11, Vol.122 (21), p.4181-4181

2013

Link zum Volltext

Verfügbarkeit prüfen

Response To 1st-Line Treatment With BR Or R-CHOP In Patients With Indolent Non-Hodgkin's Lymphoma: First Outcome Data From The German Prospective TLN Registry

Blood, 2013-11, Vol.122 (21), p.3036-3036

2013

Link zum Volltext

Verfügbarkeit prüfen

Rare lymphomas in routine practice—Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms

Hematological oncology, 2020-08, Vol.38 (3), p.344-352

2020

Link zum Volltext

Verfügbarkeit prüfen

Bendamustine Replaces Chlorambucil As “Standard of Care” in the Treatment of Elderly Patients with Chronic Lymphocytic Leukemia in German Hematology Outpatient Centres

Blood, 2012-11, Vol.120 (21), p.4605-4605

2012

Link zum Volltext

Verfügbarkeit prüfen

Bendamustine-Rituximab (BR) Replaces R-CHOP As “Standard of Care” in the Treatment of Indolent Non-Hodgkin Lymphoma in German Hematology Outpatient Centres

Blood, 2012-11, Vol.120 (21), p.3666-3666

2012

Link zum Volltext

Verfügbarkeit prüfen

Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms

Hematological oncology, 2015-03, Vol.33 (1), p.15-22

2015

Link zum Volltext

Verfügbarkeit prüfen

Non-Interventional Study Hexafil: G-CSF Use in Accordance to Guidelines?

Blood, 2012-11, Vol.120 (21), p.2057-2057

2012

Link zum Volltext

Verfügbarkeit prüfen

FDG-PET: an important tool in the diagnosis of lung cancer

Onkologie, 2007-07, Vol.30 (7), p.352-352

Abenhardt, Wolfgang

2007

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial

European journal of haematology, 2017-03, Vol.98 (3), p.254-262

2017

Link zum Volltext

Verfügbarkeit prüfen

How to Treat Chronic Lymphocytic Leukemia? Data From a Clinical Registry by Office-Based Hematologists in Germany (TLN Registry)

Blood, 2011-11, Vol.118 (21), p.4606-4606

2011

Link zum Volltext

Verfügbarkeit prüfen

Health services research: tumor registry for lymphatic neoplasia

Onkologie, 2013, Vol.36 Suppl 1, p.27

Abenhardt, Wolfgang

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumour Registry Lymphatic Neoplasms (TLN)

Oncology research and treatment, 2014, Vol.37 (11), p.635-644

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Englisch
(35)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(19)
Oncology
(18)
Aged
(15)
Female
(15)
Middle Aged
(15)
Hematology
(11)
Treatment Outcome
(11)
Adult
(10)
Male
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Chemotherapy
(8)
Registries
(8)
Patients
(7)
Aged, 80 And Over
(6)
Prospective Studies
(6)
Rituximab
(6)
Survival Rate
(6)
Tumors
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group

Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression

Versorgungsforschung: Tumorregister Lymphatische Neoplasien

Bendamustin plus Rituximab für NHL-Patienten

Similar effectiveness of R‐CHOP‐14 and ‐21 in diffuse large B‐cell lymphoma—data from the prospective German Tumour Registry Lymphatic Neoplasms

Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany

Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry

Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms

1st-Line Treatment with R-CHOP-14 or R-CHOP-21 in Patients with High-Grade Non-Hodgkin’s Lymphoma Is Similarly Effective: Data from the German Prospective TLN Registry

Consolidation with alemtuzumab improves progression‐free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long‐term follow‐up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

Response To 1st-Line Treatment With BR Or FCR In Patients With Chronic Lymphocytic Leukaemia: First Outcome Data From The German Prospective TLN Registry

Response To 1st-Line Treatment With BR Or R-CHOP In Patients With Indolent Non-Hodgkin's Lymphoma: First Outcome Data From The German Prospective TLN Registry

Rare lymphomas in routine practice—Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms

Bendamustine Replaces Chlorambucil As “Standard of Care” in the Treatment of Elderly Patients with Chronic Lymphocytic Leukemia in German Hematology Outpatient Centres

Bendamustine-Rituximab (BR) Replaces R-CHOP As “Standard of Care” in the Treatment of Indolent Non-Hodgkin Lymphoma in German Hematology Outpatient Centres

Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms

Non-Interventional Study Hexafil: G-CSF Use in Accordance to Guidelines?

FDG-PET: an important tool in the diagnosis of lung cancer

Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial

How to Treat Chronic Lymphocytic Leukemia? Data From a Clinical Registry by Office-Based Hematologists in Germany (TLN Registry)

Health services research: tumor registry for lymphatic neoplasia

Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumour Registry Lymphatic Neoplasms (TLN)

Suchergebnisse filtern